Amalgamated Bank Ngm Biopharmaceuticals Inc Transaction History

Amalgamated Bank

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 23, 2024	SELL	$1.17 - $1.92 $2,728 - $4,477	-2,332 Reduced 62.94%	1,373 $2,000
Q4 2023 Feb 06, 2024	SELL	$0.6 - $1.31 $245 - $535	-409 Reduced 9.94%	3,705 $3,000
Q2 2023 Aug 11, 2023	SELL	$2.44 - $4.53 $2,215 - $4,113	-908 Reduced 18.08%	4,114 $10,000
Q1 2023 May 02, 2023	SELL	$3.72 - $5.4 $2,957 - $4,293	-795 Reduced 13.67%	5,022 $20,000
Q3 2022 Nov 09, 2022	BUY	$12.59 - $17.67 $1,208 - $1,696	96 Added 1.68%	5,817 $76,000
Q2 2022 Aug 15, 2022	BUY	$10.58 - $17.5 $18,917 - $31,290	1,788 Added 45.46%	5,721 $73,000
Q1 2022 Jun 30, 2022	BUY	$13.81 - $18.6 $54,314 - $73,153	3,933 New	3,933 $60,000

2.6M

300

Ticker NGM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 80,365,904
Description
NGM Biopharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of novel therapeutics to treat liver and metabolic diseases, retinal diseases, and cancer. The company's product candidates include Aldafermin, an engineered analog of human hormone fibroblast growth factor 19, which is in Phase IIb clinical trial...

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

Stay updated on Amalgamated Bank with notifications on news.